POSTER SESSION VI
Wednesday, March 11, 2009   —  1:00 PM - 4:00 PM
Hynes CC Exhibit Hall C/D


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




HEMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
169 Aberrant CD56 Expression in Myelomonocytic Cells Correlates with Chromosomal Aberrations in Chronic Idiopathic Myelofibrosis (1246)
P Lin, B Feng, JL Jorgensen, S Verstovsek - UT MD Anderson Cancer Center, Houston, TX
Add
170 Flow Cytometric Panel Including CD10, CD19, CD38, CD58 and CD45 Increases Diagnostic Accuracy for Distinguishing Hematogones from Precursor B-Cell Acute Lymphoblastic Leukemia (1154)
S Alkan, R Veerappan, P Fitting, M Velankar, S Bozkurt - Loyola University Medical Center, Maywood, IL
Add
171 Pattern of Cytoplasmic IgM Expression in Hematogones: A Flow Cytometric Study (1293)
DW Sevilla, A Colovai, FN Emmons, MB Levin, G Bhagat, B Alobeid - Columbia University, New York, NY
Add
172 Distinct Expression Patterns of CD123 and CD34 on Hematogones and Blasts in Precursor B-Cell Acute Lymphoblastic Leukemia (1207)
NM Hassanein, PJ Buckley, AS Lagoo - Duke University Medical Center, Durham, NC
Add
173 Interphase FISH on TEL/AML1 Positive ALL Relapses - Possible Clinical Relevance of TEL and AML1 Copy Number Changes and Extra TEL/AML1 Copies (1209)
T Heiden, A Peter, T Taube, G Korner, K Seeger - Otto-Heubner-Center for Pediatrics, Charite Campus Virchow-Klinikum, Berlin, Germany
Add
174 Expression Profiling of Transcription Factors in Precursor Lymphoblastic Leukemia and Burkitt Lymphoma: Utility of PAX-5 Immunostaining as Pan-Pre-B-Cell Marker (1266)
MR Nasr, N Rosenthal, S Syrbu - University of Iowa Hospitals and Clinics, Iowa City, IA
Add
175 Expression of CD304 (Neuropilin-1) in Acute Leukemia and Hematopoietic Cells (1211)
LC Ho, HJ Meyerson - University Hospitals Case Medical Center, Cleveland, OH
Add
176 Correlation of Flow Cytometry and Fluorescence In-Situ Hybridization in Precursor T-Cell Lymphoblastic Leukemia (1162)
DS Bosler, CA Hanson, RA Knudson, RP Ketterling, JD Hoyer - Mayo Clinic, Rochester, MN
Add
177 Precursor T-Lymphoblastic Lymphoma: An Immunophenotypic Analysis of 186 Cases (1268)
JL Patel, MA Lones, M Abromowitch, MS Cairo, SL Perkins - University of Utah, Salt Lake City, UT; St. Joseph's Medical Center, Orange, CA; Children's Memorial Hospital of Omaha, Omaha, NE; Columbia University, New York, NY
Add
178 Acute Erythroid Leukemias - Histologic, Cytogenetic and Molecular Characterization (1326)
Z Zuo, A Kasyan, P Chandra, LJ Medeiros, H Koeppen - University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
179 Acute Promyelocytic Leukemia at Time of Relapse: Clinicopathologic Findings and Results of Ancillary Testing (1185)
ND Dimov, C Bueso-Ramos, LJ Medeiros - MD Anderson Cancer Center, Houston, TX
Add
180 Upregulation of the Developmental Regulator, SALL1, in Human Leukemias (1295)
L Shatat, S Kiefer, L Robbins, Q Xie, M Rauchman, L Grosso, H Salman - Creighton University, Omaha, NE; St Louis University, St Louis, MO
Add
181 Detection of Mono/Oligo Clonal IgH Gene Rearrangements and Characterization of Associated Clinicopathologic Features in Acute Myeloid Leukemia (1276)
X Qiu, P Lin, X Sun, J You, LJ Medeiros, CC Yin - MD Anderson Cancer Center, Houston, TX
Add
182 Comparative Analysis of 3q26 (EVI1 MDS1) Breakpoints in CML-BP and AML by Interphase FISH Using Bacterial Artificial Chromosome Probes (1219)
KJ Jabbar, P Lennon, LJ Medeiros, J Abraham, P Hu, P Lin - MD Anderson Cancer Center, Houston, TX
Add
183 Cytoplasmic Expression of Nucleophosmin Detected by Paraffin Immunohistochemistry Predicts Nucleophosmin Gene Mutations in Patients with Acute Myeloid Leukemia and Normal Karyotype (1247)
J Lou, C Qi, W Xu, J Brandwein, S Kamel-Reid, H Chang - University Health Network and University of Toronto, Toronto, Canada
Add
184 Simultaneous Detection of FLT3/ITD and NPM Mutations in AML with Normal Cytogenetics Using Formalin-Fixed, Paraffin-Embedded Bone Marrow Biopsies (1215)
Q Huang, C Chen, W Chen, LM Weiss - City of Hope National Medical Center, Duarte, CA
Add
185 CD71 (Transferrin Receptor) - An Excellent Marker for Erythroid Precursors in Bone Marrow Biopsies (1255)
DK Marsee, GS Pinkus, H Yu - Brigham and Women's Hospital, Boston, MA
Add
186 Carbonic Anhydrase I Immunohistochemistry Is Useful for Detecting Erythroid Dysplasia in Paraffin-Embedded Bone Marrow Sections (1286)
Y Sadahira, J Tsuchiyama, H Nishimura, T Akiyama, I Irei, S Hamazaki - Kawasaki Medical School, Kurashiki, Japan
Add
187 CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes (1165)
SL Butler, P Boonsakan, DD Grier, Y Li, RC Braylan, SZ Al-Quran - University of Florida, Gainesville, FL; Wake Forest University, Winston-Salem, NC
Add
188 Possible Role of Engraftment Syndrome in Myelodysplastic Syndrome after Autologous Transplants (1161)
MW Beaty, M Pettenati, DH Hurd, Y Keung - Wake Forest University School of Medicine, Winston-Salem, NC
Add
189 Myelodysplastic Syndromes Following Therapy with Purine Analogues - Therapy Related Myeloid Neoplasms? (1234)
M Kluk, C Toomey, E Hochberg, R Hasserjian - Massachusetts General Hospital, Boston, MA
Add
190 FISH Panel Testing as a Screening Tool for MDS in Elderly Patients with Anemia (1182)
KT Codispoti, L DePalma - The George Washington University Medical Center, Washington, DC
Add
191 Utility of Disease-Specific FISH Panels in the Diagnosis of Hematologic Malignancies (1269)
KP Patel, KH Ramesh, R Conte, D Wei, H Ratech, L Cannizzaro - Montefiore Medical Center, Bronx, NY
Add
192 Clinical Utility of Fluorescence In Situ Hybridization for Detection of Del(5q) in Myelodysplasia and Acute Myeloid Leukemia (1302)
Y Sun, JR Cook - Cleveland Clinic, OH
Add
193 DNA Methylation Biomarkers in Myelodysplastic Syndromes (1267)
VT Nguyen, S Nalluri, MX Wang - University of Missouri School of Medicine, Columbia, MO
Add
194 Immunophenotypic Alterations by Flow Cytometry in Patients with Granulocyte Colony Stimulating Factor Therapy May Mimic Changes Seen in Myelodysplastic Syndrome (1228)
FA Khokhar, LJ Medeiros, JL Jorgensen - UT MD Anderson Cancer Center, Houston, TX
Add
195 The Sensitivity and Specificity of Granulocyte and Monocyte Immunophenotype Abnormalities in the Detection of Myeloid Neoplasms (1274)
JM Polski - University of South Alabama, Mobile, AL
Add
196 The Specificity of Immunophenotypic Alterations in Blasts in Non-Acute Myeloid Disorders (1206)
AM Harrington, H Olteanu, SH Kroft - Medical College of Wisconsin, Milwaukee, WI
Add
197 A Flow Cytometric Protocol for Differential Diagnoses of Acute Monocytic Leukemia, Chronic Myelomonocytic Leukemia and Reactive Monocytosis (1174)
C Chen, RM Braziel, J Huang, G Fan - University of Maryland, Baltimore, MD; Oregon Health & Science University, Portland, OR
Add
198 Clinicopathologic Analysis of 18 Cases with Refractory Anemia with Ringed Sideroblasts and Thrombocytosis (1203)
I Gurevich, R Luthra, LJ Medeiros, P Lin - The University of Texas MD Anderson Cancer Center, Houston, TX
Add
199 Application of 2008 WHO Classification Criteria for Myelodysplastic Syndromes without Excess Blasts: Observations from Cancer and Leukemia Group B Study 10105 (1208)
RP Hasserjian, P Gupta, K Donohue, K Owzar, RA Larson, F Racke, CD Bloomfield - MGH, Boston, MA; University of Minnesota, Minneapolis, MN; Duke University, Durham, NC; University of Chicago, Chicago, IL; Ohio State University, Columbus, OH
Add
200 Objective Quantification of Osteosclerosis by Area Pixel Count of Bone Marrow Biopsy as a Diagnostic Tool in Myeloproliferative Neoplasms (1304)
CJ Teman, AR Wilson, SL Perkins, JT Prchal, M Salama - University of Utah, Salt Lake City, UT; ARUP Laboratories, Salt Lake City, UT
Add
201 Distinct Patterns of Marrow Fibrosis in Patients with Inherited Bone Marrow Failure Syndromes (1254)
I Maric, N Giri, D Arthur, P Noel, BP Alter - CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
Add
202 Flow Cytometric Immunophenotyping of Systemic Mastocytosis in the Bone Marrow (1220)
KJ Jabbar, Y Huh, S Wang, LJ Medeiros, MR Johnson, S Verstovsek, JL Jorgensen - UT MD Anderson Cancer Center, Houston, TX
Add
203 Myelomastocytic Leukemia: A Clinical, Pathologic, and Molecular Genetic Study (1256)
A McGuire, LR Shier, J Gotlib, B Medeiros, K Wong, C Corless, DA Arber, TI George - Stanford University, Stanford, CA; University of Alberta, Edmonton, AB, Canada; Stanford, Stanford, CA; Oregon State Health Sciences, Portland, OR
Add
204 Systemic Mastocytosis Is Frequently Masked by Its Associated Clonal Hematological Non-Mast Cell Lineage Diseases: Clinicopathologic Study of Five Cases (1301)
M Stoecker, E Wang - Duke University Medical Center, Durham, NC
Add
205 Characterization of Collagen Vascular Disease-Associated Bone Marrow Changes by Morphologic and Immunohistochemical Assessment (1218)
K Hunt, M Salama, C Sever, K Foucar - U. of New Mexico, Albuquerque, NM; U. of Utah, Salt Lake City, UT; Pathology Associates of Albuquerque, Albuquerque, NM
Add
206 Hematologic Manifestations of Copper Deficiency: One Year Experience of a Single Institution (1169)
N Cetin, K Oza, Z Singh, J Bornhorst, L Chen, R Lorsbach - University of Arkansas for Medical Sciences, Little Rock, AR; UT Medical School, Houston, TX
Add
207 Hemoglobinopathy Work-Up at Hematology Laboratory of Tufts Medical Center: 3-years Experience (1236)
S Kondratiev, SM Johnson, H-Y Luo, DHK Chui, IB Rosenwald - Tufts Medical Center, Boston, MA; Boston Medical Center, Boston, MA
Add
208 Among Alpha Thalassemia Patients, Genotypes Are Closely Associated with the Degree of Microcytosis/Mean Corpuscular Volume Values (1224)
X Jiang, D Grisak, M Lareau, MTS Rad, A Mansoor - Calgary Laboratory Services/University of Calgary, Calgary, AB, Canada
Add